Challenge IM Showcases Unmanned TFF Systems at Analytica 2026, Setting a New Benchmark in Biopharmaceutical Filtration

Munich, Germany – March 24–27, 2026 – The world’s premier analytical and life sciences trade fair, Analytica 2026, concluded successfully in Munich, bringing together thousands of leading exhibitors and tens of thousands of industry professionals from around the globe. At this flagship event, Challenge IM made a strong impression with its advanced intelligent membrane filtration systems and high-performance consumables, highlighting its comprehensive solutions for the biopharmaceutical industry.

Comprehensive Filtration Solutions on Display  

Challenge IM’s exhibition featured a full product matrix, including Tangential Flow Filtration (TFF) systems, Direct Flow Filtration (DFF) systems, and a wide range of consumables such as capsule filters, hollow fiber filters, and single-use tubing. The showcase emphasized the company’s technical strength and commitment to providing end-to-end filtration solutions for biopharmaceutical production.

From Manual to Fully Unmanned Filtration 

The highlight of the exhibition was Challenge IM’s unmanned TFF system, designed to address the key challenges of TFF processes: time consumption, labor intensity, and operational complexity. Equipped with full-process automated control technology, the system operates from parameter setting to process completion without human intervention, making it a truly “unmanned” filtration solution. Visitors were impressed by its performance, and long-time users of manual systems expressed astonishment at the system’s efficiency and reliability. This innovation represents not just an equipment upgrade, but a process revolution in biopharmaceutical filtration.

Global Recognition and Market Validation 

Challenge IM’s booth drew significant international attention, hosting clients from the United States, the United Kingdom, South Korea, and dozens of other countries. Professional technical demonstrations and detailed explanations earned the company high recognition from global visitors. Analytica 2026 marked a major milestone in Challenge IM’s globalization strategy, accelerating its international expansion and further establishing the company’s influence in the global biopharmaceutical market.

Looking Forward 

The successful conclusion of Analytica 2026 represents both a milestone and a leap forward in Challenge IM’s international strategy. Customer recognition and trust remain the driving force behind the company’s continuous innovation. Moving forward, Challenge IM will continue to provide smarter, more reliable “Made-in-China” solutions for the global biopharmaceutical industry.
From China to the world, resonating globally—Challenge IM leads the future of intelligent manufacturing.

From China to the world, resonating globally—Challenge IM leads the future of intelligent manufacturing.